Fund profile / United Kingdom

Medicxi Fund V

Geography: United Kingdom
Stage: Seed
Fund size: €500M
Focus: Biotech and Therapeutics
Signals: Published

N°01 / About

About Medicxi Fund V

Medicxi Fund V is a venture capital firm based in United Kingdom, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Biotech, Therapeutics, providing strategic guidance and capital to help startups scale.

N°02 / Thesis

Investment Focus

Location / RegionUnited Kingdom

Funding StageSeed

Industry Focus

Biotech

Therapeutics

Investor Signals Profile

active

Sweet Spot

Clinical/Phase 3 biotech founders targeting $100M+ pharma exits

biotech

pharma

life sciences

drug development

oncology

thyroid disease

vaccines

antibodies

rare diseases

hereditary disorders

Bullish Signals

€500M Fund V announcedexternal

Sanofi acquired portfolio co $1.6Bexternal

Lilly acquiring portfolio co Centessaexternal

GSK acquiring portfolio co RAPTexternal

FDA IND clearance for portfolio coexternal

3 pharma exits in quick successionexternal

Dual-paratopic antibody IND clearedexternal

Curevo acquired by Lilly shingles vaccineexternal

Ethyreal Bio $101M anti-TSHR antibodyexternal

Vaderis $152M Series B Phase 3 HHTexternal

Vicebio $1.6B Sanofi vaccine exit confirmedexternal

Centessa Lilly exit $7.8B mega-exitexternal

Centessa $7.8B Eli Lilly acquisition confirmedlinkedin

Contrarian Signals

Biotech-only, narrow sector focusexternal

Large fund — selective deal paceexternal

Founder Do's

Focus on clinical-stage assets

Show clear FDA/regulatory pathway

Target large pharma as acquirer

Vaccines & immunology welcome

First-in-class mechanisms valued

Best-in-class antibody candidates strong fit

Rare/specialty diseases attractive

Phase 3-ready programs excellent fit

Anti-TSHR & thyroid disease aligned

Hereditary/genetic disease focus strong

Founder Don'ts

Avoid non-pharma/biotech sectors

Don't pitch pre-clinical without strong data

Skip if no exit-to-pharma strategy

28 signals on Medicxi Fund V

13 bullish · 2 contrarian · 10 pitch do's · 3 don'ts, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size€500M

Saves0

Website

N°04 / See also

Related Funds

Aegon Investment Grade Climate Transition Fund I

Fund size€92M

Location: United Kingdom
Stage: Growth
Focus: Climate Sustainability
Manager: Rory Sandilands, Alexander Pelteshki, Kenneth Ward

Growth

Climate Sustainability

Energy Revolution Ventures Fund I

Fund size$18M

Location: United Kingdom
Stage: Seed
Focus: Ai Ml, Climate Sustainability
Manager: Marcus Clover

Seed

Ai Ml

Climate Sustainability

PX3 Partners Fund

Fund size€500M

Location: United Kingdom
Stage: Series A
Focus: Ecommerce, Deep Tech, Saas
Manager: Etter Johnsson, Gianpiero Lenza, Sébastien Mazella Di Bosco

Series A

Ecommerce

Deep Tech

Saas